|
Sign In to gain access to subscriptions and/or personal tools.
|
Diabetes services in primary care: are we prepared for the diabetes NSF?
Martin G Buckley
Diabetes Centre, Bolton Hospitals NHS Trust, Bolton, BL1 4AL, UK, Martin.Buckley{at}boltonh-tr.nwest.nhs.uk
Stephen N Liversedge
General Practice, Egerton/Dunscar Health Centre, Bolton, BL7 9RG, UK
John D Dean
Diabetes Centre, Bolton Hospitals NHS Trust, Bolton, BL1 4AL, UK
Aims
To conduct a survey examining issues relating to implementation of the diabetes NSF (National Service Framework) in primary care.
Methods
Fifty-two general practices were sent a questionnaire (14 questions) to investigate issues relating to implementation of the NSF for diabetes.
Results
A completed questionnaire was returned by 32 ( 60%) of practices. Of these, 30 (93.7%) had a practice register for diabetes, 18 (56.2%) had a screening policy for undiagnosed diabetes and 23 (71.9%) had specific diabetes clinics (SDC).
The practice nurse was at the front line of diabetes care, with the general practitioner, podiatrist and dietitian playing an increased role when patients had uncontrolled risk factors, or complications. In SDC lack of funding, specialist personnel and time were the main barriers to implementing the diabetes NSF.
In most practices holding SDC, patients with diabetes (65.2%) were not seen in the same clinics as patients with other cardiovascular risk problems, but without diabetes (34.8%). In those general practices not holding SDC, the majority reported they did not wish to develop these clinics (60%), due mainly to time restrictions. Only a minority (24%) of general practices referred patients with psychological problems, related to diabetes, to clinical psychology services.
Conclusion
Many general practices lack the necessary infrastructure to deliver comprehensive diabetes care and will struggle, without additional resources, to meet standards of care required, following NSF implementation.
Key Words: diabetes National Service Framework (NSF) general practice questionnaire general practitioner practice nurse podiatrist dietitian coronary heart disease (CHD).
References
- Department of Health. National Service Framework for Diabetes: Standards. London: Department of Health; 2001.
- Department of Health. National Service Framework for Diabetes: Delivery Strategy. London: Department of Health; 2003.
- Davies MJ A National Service Framework for diabetes. Br J Diabetes Vasc Dis 2001;1:123-5.[Free Full Text]
- Day C. The rising tide of type 2 diabetes. Br J Diabetes Vasc Dis 2001;1:37-43.[Abstract/Free Full Text]
- Dixon S., Currie CJ, Peters JR The cost of diabetes: time for a different approach. Diabet Med 2000;17:820-2.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The Audit Commission. Testing times: a review of diabetes services in England and Wales 2000. Department Of Health Publication, London, U.K.
- Cavn D., Fosbury J., Trigwell P. Psychology in diabetes - why bother. Pract Diab Int 2001;18:228-9.[CrossRef]
- New JP, Roxburgh MA, Vaughan NJ, Wallace C., Elliott P., Young RJ Measuring differences in the provision of diabetes care. Diabetes Nutr Metab 2001;14:104-07.[Web of Science][Medline]
[Order article via Infotrieve]
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38. BMJ 1998;317:703-13.[Abstract/Free Full Text]
- The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramapril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvistatin Survival Study. Lancet 1994;344:1383-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sanmugunathan PS, Ghahramani P., Jackson PR et al. Aspirin for primary prevention of coronary heart disease; safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 2000;85:265-71.[CrossRef][Web of Science]
- Wareham NJ, Griffin SJ Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ 2001;322:986-8.[Free Full Text]
- Lawrence JM, Bennett P., Young A., Robinson AM Screening for diabetes Ein general practice: cross sectional population study. BMJ 2001;323:548-51.[Abstract/Free Full Text]
- Borch-Johnsen K., Lauritzen T., Glumer C., Sandbaek A. Screening for Type 2 diabetes-should it be now? Diabet Med 2003;20:175-81.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Buckley MG Focus on diabetes care offers a challenge to practice nurses. Nursing Times 2003;99:14.
- Sampson MJ, Shepstone L., Greenwood RH et al. An integrated mobile foot and retinal screening programme for people with type 2 diabetes managed in primary care. Diabet Med 2002;19:74-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mykkanen L. Prevention of coronary heart disease in type 2 diabetes. Int J Clin Pract (Suppl) 2000;113:40-5.[Medline]
[Order article via Infotrieve]
- Rouse A., Adab P. Is population coronary heart disease risk screening justified? A discussion of the NSF for coronary heart disease (Standard 4). Br J Gen Pract 2001;51:834-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Buckley MG, Marcus NJ, Yacoub MH Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice. Clin Sci 1999;97:689-95.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Buckley MG, Jenkins GH, Mitchell AG, Yacoub MH, Singer DRJ. Circulating C-Type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathy. Clin Sci 2000;99:467-72.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol 2001;57:457-78.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Snoek FJ, Skinner TC Psychological counselling in problematic diabetes: does it help. Diabet Med 2002;19:265-73.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McGough N. Dietetic shortfalls that the National Service Framework for diabetes will need to address. J Hum Nutr Dietet 2001;14:485-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Pierce M., Agarwal G., Ridout D. A survey of diabetes care in general practice in England and Wales. Br J Gen Pract 2000;50:542-5.[Web of Science][Medline]
[Order article via Infotrieve]
- Farooqi A., Dodd L., Stribling B., Khunti K., Davies MJ A base line survey of diabetes service provision in a city primary care trust. Diabet Med 2003;20(suppl 2):Abs72.
- Moore W. NHS to receive an extra £40 billion over the next five years. BMJ 2002:324:993.[Free Full Text]
- Hippisley-Cox J., Pringle M. General practice workloads implications of the national service framework for coronary heart disease: cross sectional survey. BMJ 2001;323:269-70.[Free Full Text]
The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 6,
418-423 (2003)
DOI: 10.1177/14746514030030060601

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Day
NSF for Diabetes, update -- year two
The British Journal of Diabetes & Vascular Disease,
March 1, 2005;
5(2):
103 - 105.
[Abstract]
[PDF]
|
 |
|
|
|